Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Biological Psychiatry

Journal
uri icon
  • Overview
  • Identity
  • View All
scroll to property group menus

Overview

articles

  • Animal models of addiction and neuropsychiatric disorders and their role in drug discovery: honoring the legacy of Athina Markou.  83:940-946. 2018
  • Contribution to mentorship and promoting women in science.  83:913-914. 2018
  • Median and dorsal raphe serotonergic neurons control moderate versus compulsive cocaine intake.  83:1024-1035. 2018
  • Novel small-molecule inhibitors of protein kinase c epsilon reduced ethanol consumption in mice.  84:193-201. 2018
  • The lateral habenula directs coping styles under conditions of stress via recruitment of the endocannabinoid system.  84:611-623. 2018
  • Constitutive increases in amygdalar corticotropin-releasing factor and fatty acid amide hydrolase drive an anxious phenotype.  82:500-510. 2017
  • Hypocretin neurotransmission within the central amygdala mediates escalated cocaine self-administration and stress-induced reinstatement in rats.  81:606-615. 2017
  • Neuron-targeted caveolin-1 improves molecular signaling, plasticity, and behavior dependent on the hippocampus in adult and aged mice.  81:101-110. 2017
  • Novel dopamine therapeutics for cognitive deficits in schizophrenia.  81:67-77. 2017
  • Stress promotes drug seeking through glucocorticoid-dependent endocannabinoid mobilization in the prelimbic cortex.  84:85-94. 2017
  • Susceptibility and resilience to posttraumatic stress disorder-like behaviors in inbred mice.  82:924-933. 2017
  • Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders.  80:179-189. 2016
  • Corticotropin-Releasing Factor From Rodents to Primates: Translational Hope Expresses Itself, Pun Intended.  80:340-342. 2016
  • G protein-gated K+ channel ablation in forebrain pyramidal neurons selectively impairs fear learning.  80:796-806. 2016
  • Regulator of G-protein signaling 7 regulates reward behavior by controlling opioid signaling in the striatum.  80:235-245. 2016
  • Genome-wide association studies of substance use: considerations regarding populations and phenotypes..  77:423-424. 2015
  • Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans.  77:870-879. 2015
  • Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly.  77:805-815. 2015
  • The central amygdala as an integrative hub for anxiety and alcohol use disorders.  77:859-869. 2015
  • Methamphetamine-associated memory is regulated by a writer and an eraser of permissive histone methylation.  76:57-65. 2014
  • Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization.  75:96-104. 2014
  • A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.  73:721-8. 2013
  • Kappa opioid receptor-mediated dysregulation of gamma-aminobutyric acidergic transmission in the central amygdala in cocaine addiction.  74:520-528. 2013
  • Beta-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.  71:714-724. 2012
  • Nociceptin/orphanin fq blockade of corticotropin-releasing factor-induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure.  71:666-676. 2012
  • Neuropeptide y opposes alcohol effects on gamma-aminobutyric acid release in amygdala and blocks the transition to alcohol dependence.  69:1091-1099. 2011
  • Preclinical validation of a novel cocaine exposure therapy for relapse prevention.  70:593-598. 2011
  • Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: Factor in the transition to dependence.  68:240-248. 2010
  • Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence.  67:831-839. 2010
  • Effects of the mGlu2/3 agonist LY379268 and the mGlu5 antagonist MTEP on ethanol seeking and reinforcement are differentially altered in rats with a history of ethanol dependence.  67:804-811. 2010
  • Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged rats.  68:956-963. 2010
  • Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence.  66:191-195. 2009
  • The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning.  63:821-831. 2008
  • Abnormal auditory n100 amplitude: A heritable endophenotype in first-degree relatives of schizophrenia probands.  64:1051-1059. 2008
  • Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.  64:211-218. 2008
  • Inactivation of the 5-ht7 receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.  63:98-105. 2008
  • Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.  63:158-163. 2008
  • Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse.  63:152-157. 2008
  • The opioid peptides enkephalin and beta-endorphin in alcohol dependence.  64:989-997. 2008
  • Varied access to intravenous methamphetamine self-administration differentially alters adult hippocampal neurogenesis.  64:958-965. 2008
  • Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats.  61:78-86. 2007
  • Distinct patterns of neural activation associated with ethanol seeking: Effects of naltrexone.  61:979-989. 2007
  • Successful aging: From phenotype to genotype.  62:282-293. 2007
  • Tic symptom profiles in subjects with tourette syndrome from two genetically isolated populations.  61:292-300. 2007
  • A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startle.  57:1147-1152. 2005
  • Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder.  57:711-715. 2005
  • 5-HT(7) receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.  58:831-837. 2005
  • A polymorphism of the beta(1)-adrenergic receptor is associated with low extraversion.  56:217-224. 2004
  • Reduction of anxiety after restricted feeding in the rat: Implication for eating disorders.  55:1075-1081. 2004
  • Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.  54:49-58. 2003
  • Apolipoprotein d levels are elevated in prefrontal cortex of subjects with alzheimer's disease: No relation to apolipoprotein e expression or genotype.  54:136-141. 2003
  • Increased levels of apolipoprotein e in the frontal cortex of subjects with schizophrenia.  54:616-622. 2003
  • Sleep deprivation as a probe of homeostatic sleep regulation in primary alcoholics.  51:632-641. 2002
  • Auditory p3a deficits in male subjects at high risk for alcoholism.  49:726-738. 2001
  • EEG asymmetry: Relationship to mood and risk for alcoholism in Mission Indian youth.  50:129-136. 2001
  • Auditory p3a assessment of male alcoholics.  48:276-286. 2000
  • Corticotropin-releasing factor, norepinephrine, and stress.  46:1167-1180. 1999
  • Electroencephalographic responses to alcohol challenge in Native American Mission Indians.  45:776-787. 1999
  • Visual p3a in male subjects at high risk for alcoholism.  46:281-291. 1999
  • Gender differences in electrophysiological responses to facial stimuli.  44:281-289. 1998
  • Leukocyte differentials predict short-term clinical outcome following antipsychotic treatment in schizophrenia.  43:887-896. 1998
  • Anterior medial temporal lobe volumes in polydipsic schizophrenic patients with and without hypo-osmolemia: A pilot study.  42:767-770. 1997
  • Dopamine-related genes and their relationships to monoamine metabolites in csf.  40:1032-1043. 1996
  • Electrophysiological findings during the menstrual cycle in women with and without late luteal phase dysphoric disorder: Relationship to risk for alcoholism?.  39:720-732. 1996
  • Estimation of the time course of slow-wave sleep over the night in depressed patients: Effects of clomipramine and clinical response.  39:171-181. 1996
  • Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: Markers of vulnerability or disease?.  40:825-833. 1996
  • Prefrontal cortex dysfunction in borna disease virus (bdv)-infected rats.  40:629-636. 1996
  • Flinders resistant hypocholinergic rats exhibit startle sensitization and reduced startle thresholds.  36:680-688. 1994
  • Persistent effects of antidepressants - EEG sleep studies in depressed-patients during maintenance treatment.  35:781-793. 1994
  • The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers - a preliminary-report.  35:843-849. 1994
  • Effects of alcohol on the EEG in Asian men with genetic variations of ALDH2.  34:91-99. 1993
  • Effects of gender and social-isolation on electroencephalogram and neuroendocrine parameters in rats.  33:358-366. 1993
  • EEG sleep profiles and recurrent depression.  30:641-655. 1991
  • EEG fast frequency activity in the sons of alcoholics.  27:631-641. 1990
  • EEG sleep in young depressives - first and second night effects.  25:87-97. 1989
  • P300 latency after ethanol ingestion in sons of alcoholics and in controls.  24:310-315. 1988
  • Reduced beta-casein levels in milk samples from patients with postpartum psychosis.  23:115-122. 1988
  • Hypothalamic peptide modulation of EEG sleep in depression - a further application of the S-process hypothesis.  22:513-517. 1987
  • Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics.  21:23-33. 1986
  • Supersensitive endocrine response to physostigmine in dopamine-depleted rats - a model of depression.  21:775-786. 1986
  • Pharmacological treatment following experimental cerebral infarction - implications for understanding psychological symptoms of human stroke.  12:669-680. 1977
  • Norepinephrine mediated cerebellar synapses: A model system for neuropsychopharmacology.  4:157-177. 1972
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0006-3223

Electronic International Standard Serial Number (EISSN)

  • 1873-2402

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support